Vita Coco insider Form 4 shows planned stock sales in COCO

Rhea-AI Filing Summary

Vita Coco Company, Inc. director trade disclosure: A reporting person related to Vita Coco (ticker COCO) sold shares of common stock on 11/24/2025 under a pre-arranged Rule 10b5-1 trading plan. The transactions included sales of 25,381 shares at a weighted average price of $50.294 and 33,862 shares at a weighted average price of $50.271.

Following these sales, the reporting person held 498,341 shares of Vita Coco common stock directly and 602,579 shares indirectly through the Ira Liran 2012 Family Trust. The prices reflect multiple trades within stated ranges, and detailed trade-by-trade pricing is available upon request as noted in the disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liran Ira

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/24/2025		S(1)		25,381	D	$50.294(2)	498,341	D
Common Stock	11/24/2025		S(1)		33,862	D	$50.271(3)	602,579	I	by Ira Liran 2012 FT(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.65, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.62, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. These shares are held by the Ira Liran 2012 Family Trust.

	By: Alison Klein, Attorney-in-Fact For: Ira Liran	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vita Coco (COCO) report on this Form 4?

The filing reports that a Vita Coco director sold shares of the company’s common stock on 11/24/2025 in open-market transactions.

How many Vita Coco (COCO) shares were sold in the reported transactions?

The transactions included sales of 25,381 shares of common stock at a weighted average price of $50.294 and 33,862 shares at a weighted average price of $50.271.

Were the Vita Coco (COCO) insider sales made under a Rule 10b5-1 trading plan?

Yes. The filing states that the sales of common stock were effected pursuant to a Rule 10b5-1 trading plan, which is a pre-arranged plan for trading securities.

How many Vita Coco (COCO) shares does the reporting person hold after the trades?

After the reported transactions, the reporting person beneficially owned 498,341 Vita Coco common shares directly and 602,579 shares indirectly through the Ira Liran 2012 Family Trust.

What price ranges were involved in the Vita Coco (COCO) insider sales?

For the first block, shares were sold at prices ranging from $50.00 to $50.65. For the second block, shares were sold at prices ranging from $50.00 to $50.62, with weighted average prices reported for each block.

Who signed the Vita Coco (COCO) Form 4 on behalf of the reporting person?

The Form 4 was signed by Alison Klein as Attorney-in-Fact for the reporting person, Ira Liran, on 11/25/2025.